← Back to Search

Screening Interventions for Colorectal Cancer (SMARTER CRC Trial)

N/A
Recruiting
Led By Gloria Coronado, PhD
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 36 months
Awards & highlights

SMARTER CRC Trial Summary

This trial is looking at how to best reduce colorectal cancer rates in the US by partnering clinics with health plans. They hope to improve screening and follow-up rates in rural Medicaid patients.

Who is the study for?
This trial is for Medicaid patients aged 45-75 in rural areas who need colorectal cancer screening. Clinics and staff willing to participate, collect data, and implement the intervention are eligible. Excluded are those current on screenings or with conditions making them poor candidates.Check my eligibility
What is being tested?
The study tests a model using interviews, fecal immunochemical testing, and patient navigation to increase colorectal cancer screening rates in rural settings through clinic-health plan partnerships.See study design
What are the potential side effects?
Since this trial involves non-invasive procedures like interviews and fecal tests rather than medication or surgery, side effects are minimal but may include discomfort or anxiety from discussing personal health issues.

SMARTER CRC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Colorectal Carcinoma
Secondary outcome measures
Adaptations to core program components made by payer or clinic
Adenomas or cancers detected
Colonoscopy referral
+9 more

SMARTER CRC Trial Design

2Treatment groups
Active Control
Group I: SMARTER CRC Intervention Year 1Active Control3 Interventions
In year 1, patients receive mailed FITs from CCO, screening reminders from clinics, and patient navigation as appropriate; Health record data collected.
Group II: SMARTER CRC Intervention Year 2Active Control3 Interventions
In year 2, patients receive mailed FITs from CCO, screening reminders from clinics, and patient navigation as appropriate; Health record data collected.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,721 Previous Clinical Trials
40,947,366 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
980 Previous Clinical Trials
7,369,034 Total Patients Enrolled
OHSU Knight Cancer InstituteLead Sponsor
231 Previous Clinical Trials
2,072,980 Total Patients Enrolled

Media Library

Fecal Immunochemical Test Clinical Trial Eligibility Overview. Trial Name: NCT04890054 — N/A
Colorectal Cancer Research Study Groups: SMARTER CRC Intervention Year 1, SMARTER CRC Intervention Year 2
Colorectal Cancer Clinical Trial 2023: Fecal Immunochemical Test Highlights & Side Effects. Trial Name: NCT04890054 — N/A
Fecal Immunochemical Test 2023 Treatment Timeline for Medical Study. Trial Name: NCT04890054 — N/A
~907 spots leftby Aug 2024